About this trial
Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). To shed light on this problem, the current studies were designed. In sub-study 1, deceased patients with CVC who are referred for clinical autopsy are included. Before the autopsy, the deceased will be examined with a photon-counting computed tomography (CT) scan and the results will be compared.
In sub-study 2, living patients with CVC who are referred for various CT scans without contrast, are included. After informed consent, the patient will be examined with the photon-counting CT, whose reliability has been validated in Part 1 and the incidence of subclinical CVC-related thrombosis will be reported.
Eligibility criteria
Qualifiers
Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy
Informed and signed consent from next of kind
Disqualifiers
None
Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
Informed and signed consent from the patient
Trial design
Treatments tested in this trial
- Diseased patients with an indwelling central venous catheter who is referred to autopsy
- Living patients with an indwelling central venous catheter referred to a CT scan without iv contrast
Treatment groups
Sponsors and collaborators
Thomas Kander
Lead sponsor
Region Skane
Sponsor institution